UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting
Retrieved on:
Thursday, April 20, 2023
BRUSSELS and ATLANTA, April 20, 2023 /PRNewswire/ -- UCB will showcase data from its expansive and innovative neurology portfolio at the 75th American Academy of Neurology (AAN) Annual Meeting, April 22-27, 2023.
Key Points:
- BRUSSELS and ATLANTA, April 20, 2023 /PRNewswire/ -- UCB will showcase data from its expansive and innovative neurology portfolio at the 75th American Academy of Neurology (AAN) Annual Meeting, April 22-27, 2023.
- The company will present 12 abstracts, including two oral presentations, across generalized myasthenia gravis (gMG), Lennox-Gastaut syndrome (LGS), and focal (partial) epileptic seizures.
- In gMG, presentations will expand on the results from the MycarinG and RAISE studies1,2.
- Charl van Zyl, Executive Vice President Neurology and Head of EU/International Markets, UCB, said: "Our presentations at AAN reinforce the strength and depth of our expanding rare disease pipeline and portfolio.